SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-15-041693
Filing Date
2015-07-09
Accepted
2015-07-09 06:00:53
Documents
7
Period of Report
2015-07-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K v415129_8k.htm 8-K 25346
2 EXHIBIT 10.1 v415129_ex10-1.htm EX-10.1 15885
3 EXHIBIT 10.2 v415129_ex10-2.htm EX-10.2 89246
4 EXHIBIT 10.3 v415129_ex10-3.htm EX-10.3 64295
5 EXHIBIT 10.4 v415129_ex10-4.htm EX-10.4 33282
6 GRAPHIC tpg02.jpg GRAPHIC 16416
7 GRAPHIC tpg16.jpg GRAPHIC 27486
  Complete submission text file 0001144204-15-041693.txt   290272
Mailing Address 155 GIBBS STREET SUITE 412 ROCKVILLE MD 20850
Business Address 617 DETROIT STREET, SUITE 100 ANN ARBOR MI 48104 (734) 332-7800
Synthetic Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

IRS No.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12584 | Film No.: 15980393
SIC: 2834 Pharmaceutical Preparations